论文部分内容阅读
作者报道1981 1986年期间应用羟基脲治疗伴有血小板增多的真性红细胞增多症(PV)24例,特发性血小板增多症(ET)25例和骨髓纤维化(MF)10例的经验。ET患者的血小板计数(PLT)>800×10~9/L,也包括2例ET的PLT<800×10~9/L但有严重症状且符合其他诊断标准。9/10 MF患者的PLT>500×10~9/L。用法:羟基脲胶囊500mg每日1-3次,开始1000-2000mg/日,根据外周血计数迅速调整,开始每隔1-2周观察患者,但3月后,根据每4-6周所得血计数调整剂量;1年后则为隔8 12周。治疗目的是维持良好的血液学计数,即使PLT<400×10~9/L
The authors report the experience of applying hydroxyurea in the treatment of 24 cases of polycythemia vera (thrombocytopenia) with thrombocytosis (25 cases), 25 cases of idiopathic thrombocythemia (ET) and 10 cases of myelofibrosis (MF) ET patients with platelet count (PLT)> 800 × 10 ~ 9 / L, including 2 cases of ET PLT <800 × 10 ~ 9 / L but with serious symptoms and meet other diagnostic criteria. PLT in 9/10 MF patients was> 500 × 10 ~ 9 / L. Usage: Hydroxyurea capsules 500mg daily 1-3 times, starting 1000-2000mg / day, according to the rapid adjustment of peripheral blood count began to observe the patients every 1-2 weeks, but after 3 months, according to the blood of every 4-6 weeks Dose adjustment dose; 1 year after the interval of 8 12 weeks. The goal of treatment is to maintain a good hematologic count, even if PLT <400 × 10-9 / L